Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Biosurgery Market Worth $7.6B by 2022 Growing at 3.6% CAGR

RnR Market Research
Posted on: 27 Sep 16

PR Newswire

PUNE, India, September 27, 2016

PUNE, India, September 27, 2016 /PRNewswire/ --

indiaRnRMarketResearch.com adds "MediPoint: Biosurgery - Global Analysis and Market Forecast" to its store providing analysis of the biosurgery space across the 15 major markets of the US, Canada, Mexico, France, Germany, Italy, Spain, Russia, the UK, Japan, China, India, South Korea, Australia, and Brazil. It includes annualized biosurgery market revenues by segment from 2015 and forecast to 2022. This report was built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis conducted by GlobalData's team of industry experts. It state that drivers of this growth, which will occur across 15 major markets, include aging populations in many countries, rising disease rates that necessitate a greater number of surgical interventions, and improving healthcare infrastructures in emerging countries that allow for more advanced therapies to be adopted.

The global biosurgery market, which covers hemostats, tissue sealants, tissue adhesives, and surgical adhesion barriers, is set to rise from $6 billion in 2015 to $7.6 billion by 2022, representing a steady compound annual growth rate of 3.6%. Complete report on Biosurgery Market Research 2022 with 91 market data tables and 60 figures, spread across 175 pages is available at http://www.rnrmarketresearch.com/medipoint-biosurgery-global-analysis-and-market-forecast-market-report.html .

Companies discussed in this research report are B. Braun, Atrium Medical, Baxter, C.R. Bard, CryoLife, Gelita, Sanofi, Integra LifeSciences, Ethicon Endo-Surgery (Johnson & Johnson), Medtronic, Pfizer, Stryker, Takeda, 3-D Matrix Medical Technology, Adhezion Biomedical, Anika Therapeutics, BioActive Polymers, Chemence Medical, Cohera Medical, Gecko Biomedical, Hemostasis, LLC, HyperBranch Medical Technology, Mallinckrodt, Mast Biosurgery, OptMed, Sealantis, Vivostat, Abbott Nutrition, ALCOR Scientific, Applied Medical Technology, B. Braun Melsungen AG, Boston Scientific, ConMed, Cook Medical, Covidien, C.R. Bard, Fresenius Kabi, Halyard Health, Medline, Moog, Nestlé Health Science, Nutricia and Vygon.

Prompt hemostasis, effective incision closure, tissue and vessel sealing, and post-operative adhesion prevention have been paramount concerns for surgeons for decades. As medical technology advances, the surgeon's toolbox expands to include more effective products that actively cease bleeding, close external and internal ruptures in tissue, and provide physical barriers between tissues to prevent dangerous adhesions. These biosurgery products have become indispensable keystones in any operating room environment.

Key Findings: Emerging economies are seeing the highest growth in the global biosurgery market. Hemostats and tissue sealants make up the largest portions of the market in many countries because they are widely used in a variety of different surgical specialties. The most successful firms involved in biosurgery are providing comprehensive portfolios, undertaking key M&A's, fostering innovation, and focusing wisely on emerging markets to stay competitive. Rising numbers of different surgical procedures are the primary drivers of the biosurgery market. Despite respectable adoption, unmet needs and non-clinical barriers remain a challenge.

Order a copy of this 2016 biosurgery market report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=692177.  

Another newly published market research report titled Sutures - Medical Devices Pipeline Assessment, 2016 provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Sutures pipeline products. The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities. The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage. Companies mentioned in this research report are Advanced Medical Solutions Group plc, Cellceutix Corporation, Ethicon, Inc., John Hopkins University, Ligadon, MiMedx Group, Inc, NuVascular Technologies Inc and Tepha, Inc. Sutures market research report of 39 pages is available at http://www.rnrmarketresearch.com/sutures-medical-devices-pipeline-assessment-2016-market-report.html .

Explore more reports on Surgical Equipment.

About Us: 

RnRMarketResearch.com is your single source for all market research needs. Our database includes 100,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports. We provide 24/7 online and offline support to our customers.

Contact:  
Ritesh Tiwari
2nd floor, Metropole,
Next to Inox theatre, Bund garden road,
Pune-411001
Maharashtra, India.
+1 888 391 5441
sales@rnrmarketresearch.com


SOURCE RnR Market Research

PR Newswire
www.prnewswire.com

Last updated on: 27/09/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.